南微医学收盘上涨9.34%，滚动市盈率30.41倍，总市值173.55亿元

Core Viewpoint - Nanwei Medical's stock price closed at 92.39 yuan, up 9.34%, with a rolling PE ratio of 30.41, marking a new low in 387 days, and a total market capitalization of 17.355 billion yuan [1] Group 1: Company Performance - For the first half of 2025, Nanwei Medical reported revenue of 1.565 billion yuan, a year-on-year increase of 17.36%, and a net profit of 363 million yuan, also up 17.04%, with a gross profit margin of 64.89% [1] - The company specializes in the research, manufacturing, and sales of minimally invasive medical devices, with key products including endoscopic diagnostic instruments, microwave/radiofrequency ablation equipment and consumables, and disposable endoscopes [1] Group 2: Shareholder Information - As of June 30, 2025, Nanwei Medical had 12,345 shareholders, a decrease of 968 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 3: Industry Comparison - The average PE ratio for the medical device industry is 56.56, with a median of 39.76, placing Nanwei Medical at the 58th position in the industry ranking [1][2] - The static PE ratio for Nanwei Medical is 31.37, and the price-to-book ratio is 4.31 [2]